Developer docs
API playgroundTry for free, no card

Search company profiles

Eucalyptus

Full company profile

uuid00006lr

Namestring
Eucalyptus
Legal namestring
EUC Services Pty Ltd
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Eucalyptus is a Sydney-headquartered digital telehealth operator founded in 2019 that runs a portfolio of demographic-focused online clinics on a shared proprietary platform. Its sub-brands include Juniper (women's weight management, launched 2021, operating in Australia, UK, Germany and Japan), Pilot (men's health, founded 2019), Kin (reproductive healthcare, founded 2020), Software (clinical-grade tele-skincare, founded 2020), and Compound. The underlying Eucalyptus platform is custom-built and includes modules for consultation, pathology, flexible plans, purchasing, chat, tracking and medical records, with role-specific views for practitioners and patients; it integrates with Australia's eRx electronic prescription exchange and IHI database, and meets NHS DSPT requirements and CQC/GPhC regulations in the UK. The company has facilitated over 1 million practitioner consultations and serves more than 775,000 customers, with an in-house multidisciplinary clinical team of 80+ practitioners across GPs, nurse practitioners, pharmacists and dietitians.

Eucalyptus generates revenue primarily through subscription-based care programs that bundle clinician consultations, ongoing coaching, prescriptions and shipped treatments across its four consumer clinics. The flagship Juniper program combines pharmacotherapy (semaglutide and tirzepatide) with multidisciplinary health coaching delivered via an award-winning native mobile app and a proprietary trends engine; Software additionally sells custom and over-the-counter skincare through Priceline Pharmacy retail in Australia. The company does not publicly disclose specific program pricing.

In February 2026, NYSE-listed Hims & Hers Health announced a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million in cash at closing plus deferred and earnout payments through early 2029; the deal closed in June 2026. At acquisition announcement, Eucalyptus disclosed ARR exceeding US$450 million with triple-digit year-over-year growth across every quarter of 2025. Co-founder Tim Doyle transitioned to SVP of International at Hims & Hers, and the post-acquisition entity has subsequently announced collaborations with Novo Nordisk for branded Wegovy/Ozempic distribution and an AI agent integration with Amigo.

Short descriptiontext

Eucalyptus is a Sydney-based telehealth operator that runs multiple demographic-focused online clinics (Juniper, Pilot, Kin, Software, Compound) on a shared proprietary platform, delivering subscription-based chronic care across Australia, the UK, Germany, Japan and Canada.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
telehealth services, digital health clinics, weight management programs, online prescription services, consumer healthcare subscriptions
Industry2 codes
1Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care)
CodeHLALAFAKPrimaryYes
2Women’s & Family Health Provider Marketplaces
CodeHLALALAKPrimaryNo
NAICS code3 codes
  • Home Health Care Services62161
  • Offices of Physicians6211
  • Offices of Other Health Practitioners6213
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Telehealth Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Telehealth Programs
TypeSubscription Recurring
Description

Recurring subscription-based care programs delivered through Eucalyptus' four digital clinics (Kin reproductive care, Pilot men's health, Juniper weight management, Software skincare). Patients pay ongoing fees for consults, ongoing support, prescriptions, and shipped treatments. Juniper programs combine medication with multidisciplinary health coaching via app-based delivery.

eucalyptus.health
2Skincare Product Sales (Software)
TypeHardware Sales
Description

Sale of clinical-grade custom skincare formulations (over 70,000 custom formulations to date) and over-the-counter skincare offerings through retail partners including Priceline Pharmacy in Australia. Combines bespoke subscription delivery with retail product revenue.

eucalyptus.health
3Contraceptive Pill Delivery (Kin)
TypeSubscription Recurring
Description

Recurring delivery service for contraceptive pills with over 50,000 subscribers. Includes ongoing prescriptions and delivery of medication as part of a subscription model.

eucalyptus.health
4Telehealth Consultation & Treatment Fees
TypeTransaction Fee
Description

Per-consult and treatment-related fees across clinics, including consultations with GPs, nurse practitioners, pharmacists, and dietitians. Treatment plans integrate medication dispensing and pharmacist fulfilment where applicable.

eucalyptus.health
Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Operations, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1Juniper
Description

Women's weight management telehealth clinic operating in Australia, the UK, Germany, and Japan; supported 200,000 Australian women with personalised weight treatment.

eucalyptus.health
+4 more records
Core offering1 text field

Eucalyptus operates a portfolio of subscription-based direct-to-consumer telehealth clinics (Juniper for women's weight management, Pilot for men's health, Kin for reproductive healthcare, Software for clinical-grade skincare, and Compound) delivered through its proprietary digital health platform. Patients access asynchronous and synchronous consultations with certified practitioners, receive clinician-prescribed medication, ongoing multidisciplinary coaching, and in some cases bespoke compounded or OTC treatments, paying recurring subscription fees for ongoing care and prescriptions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • Over 1 million practitioner consultations facilitated since 2019
+9 more records
Product overview1 text field

Eucalyptus operates a platform-plus-modules architecture: a single shared underlying telehealth platform (the "Eucalyptus Platform") powers a portfolio of distinct, demographic-focused digital healthcare clinic sub-brands — Pilot (men's health), Juniper (women's weight management — flagship), Kin (reproductive healthcare), Software (clinical-grade tele-skincare) and Compound — supported by shared capabilities such as the Health Records, Chat, Trends Engine, Consultation, Pathology, Flexible Plans, Purchasing and Tracking modules. The company is best known for its Juniper weight-management service, which combines clinician-prescribed pharmacotherapy (semaglutide, tirzepatide, Wegovy, Ozempic, Mounjaro) with multidisciplinary health coaching, an award-winning patient mobile app and a health-coaching trends engine; Juniper operates in Australia, the UK, Germany and Japan. Pilot, Kin and Software round out the portfolio for men's health, fertility/reproductive care and skincare respectively, and since mid-2026 Eucalyptus has operated as a subsidiary of Hims & Hers Health following a US$1.15B acquisition.

Product and service5 records
1Juniper (women's weight management clinic)
CategoryWeight management telehealth
Description

Subscription-based telehealth weight management clinic for women combining clinician-prescribed medication with ongoing multidisciplinary health coaching via app and asynchronous/synchronous consults; supports 200,000+ Australian women and operates in Australia, UK, Germany and Japan.

2Pilot (men's health clinic)
CategoryMen's health telehealth
Description

Subscription telehealth clinic for men's health covering hair loss, erectile dysfunction, premature ejaculation, herpes and weight gain, with free mental-health counselling via TIACS; serving 100,000+ men in Australia.

3Kin (reproductive healthcare clinic)
CategoryReproductive healthcare telehealth
Description

Subscription telehealth clinic for women's reproductive healthcare offering fertility care, recurring contraceptive pill delivery (50,000+ subscribers), and postpartum support, plus advocacy campaigns such as #weneedmoreleave and #BreastFeedingFriendly.

4Software (clinical-grade tele-skincare)
CategorySkincare telehealth
Description

Subscription telehealth skincare clinic offering bespoke, clinical-grade custom skincare formulations for acne, redness, pigmentation and skin ageing (70,000+ custom formulations) plus over-the-counter skincare products distributed at Priceline Pharmacy from 2023.

5Compound (digital health clinic)
CategoryDigital health telehealth clinic
Description

Eucalyptus digital clinic operating under compound.co, compound.health and compound.healthcare domains, referenced in the company's vulnerability disclosure programme and careers page with Lead Clinician Dr Ben Condon.

Scale indicator26 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-05-28
Description

Hims & Hers added eight new partner brands to its subscriber benefits program post-acquisition, including Natural Cycles, MyFitnessPal, Ladder, Pvolve, HelloFresh, Factor, Flo Health, Dexcom (Stelo), and iFIT, offering discounts and free trials across fitness, nutrition, women's health, and metabolic monitoring.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-12
Description

Novo Nordisk and Hims & Hers settled a prior patent lawsuit and announced a collaboration to distribute Wegovy and Ozempic through the combined Hims & Hers-Eucalyptus telehealth platform, phasing out mass marketing of compounded versions. This gives Novo Nordisk access to Hims & Hers' telehealth customer base (over 418,000 GLP-1 users) and reshapes Eucalyptus' weight-loss distribution into branded pharmaceutical channels.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-19
Description

Hims & Hers Health entered into a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million cash at closing plus deferred and earnout payments through early 2029. The deal closed in mid-2026. Eucalyptus founder Tim Doyle became SVP of International at Hims & Hers, expanding its consumer health platform across Australia, the UK, Canada, Germany, France, Ireland, Spain, and Japan.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-08-01
Description

Amigo has partnered with Eucalyptus to integrate AI agents into its portfolio of specialised virtual clinics, launching initially at Juniper (women's weight management) before expanding to other brands. The collaboration automates routine clinical tasks and provides round-the-clock patient support.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-01
Description

In 2023, Software's high-performance OTC skincare offerings hit the shelves across retail partners in Australia, including Priceline Pharmacy, extending the brand's distribution beyond the Software telehealth channel.

Strategic tierModerateTypeGTM or Marketing PartnerAnnounced on2019-01-01
Description

Since 2019, Eucalyptus' Pilot brand has partnered with TIACS to offer men free, confidential mental health counselling via call or text. Pilot provides funding and the partnership supports brand reputation in men's health while extending patient access to crisis support services.

Strategic tierFlagshipTypeOthers
Description

Eucalyptus is the only telehealth company accredited by ACHS against the EQuIP6 standard, providing independent validation of clinical governance, patient safety and quality systems. ACHS accreditation is a strong differentiator versus other Australian telehealth operators.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

UK diagnostic and pathology partner used by Eucalyptus to facilitate blood-testing services in the UK. Both parties act as separate and independent data controllers for the testing data.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

UK diagnostic and pathology partner used by Eucalyptus for at-home blood-testing kits and lab analysis. Both parties act as separate and independent data controllers for the testing data.

Strategic tierCoreTypeTechnology or Integration
Description

Eucalyptus has integrated with Australia's Individual Healthcare Identifier (IHI) database, allowing practitioners to validate patient identity and clinical history as part of safe prescribing workflows.

Strategic tierCoreTypeTechnology or Integration
Description

Eucalyptus has integrated with Australia's eRx electronic prescription exchange to enable paperless prescribing and dispensing workflows across its clinics.

Recent move13 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeDirect peer
Description

US-based direct-to-consumer telehealth operator running Roman (men's health), Rory (women's health) and Ro Body (weight management). Closely comparable to Eucalyptus in multi-brand D2C prescribing model, subscription revenue structure and category mix across men's, women's and chronic care.

TypeBroad incumbent
Description

NYSE-listed direct-to-consumer telehealth platform (HIMS) selling prescription and OTC treatments across hair, skin, sexual health, mental health and weight loss. Now Eucalyptus' parent company following the US$1.15B June 2026 acquisition, making it the closest functional peer and the channel through which Eucalyptus' brands now reach US consumers.

TypeBroad incumbent
Description

NYSE-listed global virtual care incumbent offering telehealth across primary care, mental health, chronic condition management and weight management (via Livongo acquisition). Broad incumbent peer providing enterprise and consumer virtual care at much larger scale than Eucalyptus.

TypeDirect peer
Description

Virtual clinic for women's and family health covering fertility, maternity, postpartum and ongoing care. Directly comparable to Eucalyptus' Kin Fertility brand and adjacent to Juniper's women's weight-management focus.

TypeRegional player
Description

Germany-focused online telehealth and pharmacy platform offering prescription treatments across weight management, men's health and dermatology. Regional peer in Germany where Eucalyptus operates Juniper Germany, with overlapping category mix.

TypeEmerging player
Description

Personalised nutrition and metabolic health platform using at-home tests and consumer subscription coaching, with growing weight-management and cardiometabolic positioning. Emerging peer to Eucalyptus in consumer chronic-condition management with a science-led, evidence-base approach.

TypeBroad incumbent
Description

UK-founded digital health company offering AI-assisted triage, telehealth consultations and chronic-condition management globally. A broad incumbent peer in the UK/Europe telehealth market where Eucalyptus' Juniper and other brands operate.

TypeDirect peer
Description

UK-based D2C telehealth clinic treating men's health conditions (hair loss, erectile dysfunction, weight loss) via subscription. Direct peer to Eucalyptus' Pilot brand and representative of the same UK men's-health D2C category where Eucalyptus competes.

TypeDirect peer
Description

European online clinic operating across the UK, Germany, France and Ireland offering consultations, prescriptions and ongoing care for chronic and lifestyle conditions. Comparable to Eucalyptus in cross-European D2C prescription telehealth model and multi-country compliance footprint.

TypeDirect peer
Description

US-headquartered digital health platform combining behaviour change coaching with clinician-prescribed weight-loss pharmacotherapy (GLP-1 support). Closest pure-play peer to Eucalyptus' Juniper in combining coaching, app and prescription weight-management at scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eucalyptus

Telehealth Healthcare Serviceseucalyptus.health

Eucalyptus is a Sydney-based telehealth operator that runs multiple demographic-focused online clinics (Juniper, Pilot, Kin, Software, Compound) on a shared proprietary platform, delivering subscription-based chronic care across Australia, the UK, Germany, Japan and Canada.

What Eucalyptus does

Eucalyptus is a Sydney-headquartered digital telehealth operator founded in 2019 that runs a portfolio of demographic-focused online clinics on a shared proprietary platform. Its sub-brands include Juniper (women's weight management, launched 2021, operating in Australia, UK, Germany and Japan), Pilot (men's health, founded 2019), Kin (reproductive healthcare, founded 2020), Software (clinical-grade tele-skincare, founded 2020), and Compound. The underlying Eucalyptus platform is custom-built and includes modules for consultation, pathology, flexible plans, purchasing, chat, tracking and medical records, with role-specific views for practitioners and patients; it integrates with Australia's eRx electronic prescription exchange and IHI database, and meets NHS DSPT requirements and CQC/GPhC regulations in the UK. The company has facilitated over 1 million practitioner consultations and serves more than 775,000 customers, with an in-house multidisciplinary clinical team of 80+ practitioners across GPs, nurse practitioners, pharmacists and dietitians.

Eucalyptus generates revenue primarily through subscription-based care programs that bundle clinician consultations, ongoing coaching, prescriptions and shipped treatments across its four consumer clinics. The flagship Juniper program combines pharmacotherapy (semaglutide and tirzepatide) with multidisciplinary health coaching delivered via an award-winning native mobile app and a proprietary trends engine; Software additionally sells custom and over-the-counter skincare through Priceline Pharmacy retail in Australia. The company does not publicly disclose specific program pricing.

In February 2026, NYSE-listed Hims & Hers Health announced a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million in cash at closing plus deferred and earnout payments through early 2029; the deal closed in June 2026. At acquisition announcement, Eucalyptus disclosed ARR exceeding US$450 million with triple-digit year-over-year growth across every quarter of 2025. Co-founder Tim Doyle transitioned to SVP of International at Hims & Hers, and the post-acquisition entity has subsequently announced collaborations with Novo Nordisk for branded Wegovy/Ozempic distribution and an AI agent integration with Amigo.

Eucalyptus firmographics

Firmographics
Name
Eucalyptus
Legal name
EUC Services Pty Ltd
Website
https://eucalyptus.health
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
251–500 employees
Short description
Eucalyptus is a Sydney-based telehealth operator that runs multiple demographic-focused online clinics (Juniper, Pilot, Kin, Software, Compound) on a shared proprietary platform, delivering subscription-based chronic care across Australia, the UK, Germany, Japan and Canada.
Ownership category
akta.pro rank

Eucalyptus industry classification

Industry
Product category
Telehealth Healthcare Services
NAICS
Home Health Care Services (62161), Offices of Physicians (6211), Offices of Other Health Practitioners (6213)
SIC
Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)
akta.pro secondary industry
Women’s & Family Health Provider Marketplaces (HLALALAK)

Keywords

  • Telehealth services
  • Digital health clinics
  • Weight management programs
  • Online prescription services
  • Consumer healthcare subscriptions

Where Eucalyptus is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices6 records

Markets served

Eucalyptus business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Operations, Infrastructure

Revenue model

  1. Subscription Telehealth Programs: Recurring subscription-based care programs delivered through Eucalyptus' four digital clinics (Kin reproductive care, Pilot men's health, Juniper weight management, Software skincare). Patients pay ongoing fees for consults, ongoing support, prescriptions, and shipped treatments. Juniper programs combine medication with multidisciplinary health coaching via app-based delivery.
  2. Skincare Product Sales (Software): Sale of clinical-grade custom skincare formulations (over 70,000 custom formulations to date) and over-the-counter skincare offerings through retail partners including Priceline Pharmacy in Australia. Combines bespoke subscription delivery with retail product revenue.
  3. Contraceptive Pill Delivery (Kin): Recurring delivery service for contraceptive pills with over 50,000 subscribers. Includes ongoing prescriptions and delivery of medication as part of a subscription model.
  4. Telehealth Consultation & Treatment Fees: Per-consult and treatment-related fees across clinics, including consultations with GPs, nurse practitioners, pharmacists, and dietitians. Treatment plans integrate medication dispensing and pharmacist fulfilment where applicable.

Go-to-market motion1 record

Distribution channels4 records

Eucalyptus product offering

Product offering

Core offering

Eucalyptus operates a portfolio of subscription-based direct-to-consumer telehealth clinics (Juniper for women's weight management, Pilot for men's health, Kin for reproductive healthcare, Software for clinical-grade skincare, and Compound) delivered through its proprietary digital health platform. Patients access asynchronous and synchronous consultations with certified practitioners, receive clinician-prescribed medication, ongoing multidisciplinary coaching, and in some cases bespoke compounded or OTC treatments, paying recurring subscription fees for ongoing care and prescriptions.

Product overview

Eucalyptus operates a platform-plus-modules architecture: a single shared underlying telehealth platform (the "Eucalyptus Platform") powers a portfolio of distinct, demographic-focused digital healthcare clinic sub-brands — Pilot (men's health), Juniper (women's weight management — flagship), Kin (reproductive healthcare), Software (clinical-grade tele-skincare) and Compound — supported by shared capabilities such as the Health Records, Chat, Trends Engine, Consultation, Pathology, Flexible Plans, Purchasing and Tracking modules. The company is best known for its Juniper weight-management service, which combines clinician-prescribed pharmacotherapy (semaglutide, tirzepatide, Wegovy, Ozempic, Mounjaro) with multidisciplinary health coaching, an award-winning patient mobile app and a health-coaching trends engine; Juniper operates in Australia, the UK, Germany and Japan. Pilot, Kin and Software round out the portfolio for men's health, fertility/reproductive care and skincare respectively, and since mid-2026 Eucalyptus has operated as a subsidiary of Hims & Hers Health following a US$1.15B acquisition.

Differentiator

Problem solved

Functional benefit

Brands

  • Juniper: Women's weight management telehealth clinic operating in Australia, the UK, Germany, and Japan; supported 200,000 Australian women with personalised weight treatment.
  • Pilot
  • Kin
  • Software
  • Compound

Products and services

  • Juniper (women's weight management clinic) Subscription-based telehealth weight management clinic for women combining clinician-prescribed medication with ongoing multidisciplinary health coaching via app and asynchronous/synchronous consults; supports 200,000+ Australian women and operates in Australia, UK, Germany and Japan.
  • Pilot (men's health clinic) Subscription telehealth clinic for men's health covering hair loss, erectile dysfunction, premature ejaculation, herpes and weight gain, with free mental-health counselling via TIACS; serving 100,000+ men in Australia.
  • Kin (reproductive healthcare clinic) Subscription telehealth clinic for women's reproductive healthcare offering fertility care, recurring contraceptive pill delivery (50,000+ subscribers), and postpartum support, plus advocacy campaigns such as #weneedmoreleave and #BreastFeedingFriendly.
  • Software (clinical-grade tele-skincare) Subscription telehealth skincare clinic offering bespoke, clinical-grade custom skincare formulations for acne, redness, pigmentation and skin ageing (70,000+ custom formulations) plus over-the-counter skincare products distributed at Priceline Pharmacy from 2023.
  • Compound (digital health clinic) Eucalyptus digital clinic operating under compound.co, compound.health and compound.healthcare domains, referenced in the company's vulnerability disclosure programme and careers page with Lead Clinician Dr Ben Condon.

Quantifiable outcome

  • Over 1 million practitioner consultations facilitated since 2019
  • +9 more outcomes

Companies that use Eucalyptus

Customer profile

Named customers1 record

Ideal customer profiles3 records

Eucalyptus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability9 records

Feature6 records

Eucalyptus partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, flagship and moderate.

  • Hims & Hers Subscriber Benefits Brand PartnerscoreGTM or Marketing Partner · 28 May 2026Hims & Hers added eight new partner brands to its subscriber benefits program post-acquisition, including Natural Cycles, MyFitnessPal, Ladder, Pvolve, HelloFresh, Factor, Flo Health, Dexcom (Stelo), and iFIT, offering discounts and free trials across fitness, nutrition, women's health, and metabolic monitoring.
  • Novo NordiskflagshipStrategic or Co-development Partner · 12 March 2026Novo Nordisk and Hims & Hers settled a prior patent lawsuit and announced a collaboration to distribute Wegovy and Ozempic through the combined Hims & Hers-Eucalyptus telehealth platform, phasing out mass marketing of compounded versions. This gives Novo Nordisk access to Hims & Hers' telehealth customer base (over 418,000 GLP-1 users) and reshapes Eucalyptus' weight-loss distribution into branded pharmaceutical channels.
  • Hims & Hers Health, Inc.flagshipStrategic or Co-development Partner · 19 February 2026Hims & Hers Health entered into a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million cash at closing plus deferred and earnout payments through early 2029. The deal closed in mid-2026. Eucalyptus founder Tim Doyle became SVP of International at Hims & Hers, expanding its consumer health platform across Australia, the UK, Canada, Germany, France, Ireland, Spain, and Japan.
  • Amigo (AI Health Platform)flagshipTechnology or Integration · 1 August 2025Amigo has partnered with Eucalyptus to integrate AI agents into its portfolio of specialised virtual clinics, launching initially at Juniper (women's weight management) before expanding to other brands. The collaboration automates routine clinical tasks and provides round-the-clock patient support.
  • Priceline PharmacycoreChannel Partner/ Reseller/ Distributor · 1 January 2023In 2023, Software's high-performance OTC skincare offerings hit the shelves across retail partners in Australia, including Priceline Pharmacy, extending the brand's distribution beyond the Software telehealth channel.
  • TIACS (This Is A Conversation Starter)moderateGTM or Marketing Partner · 1 January 2019Since 2019, Eucalyptus' Pilot brand has partnered with TIACS to offer men free, confidential mental health counselling via call or text. Pilot provides funding and the partnership supports brand reputation in men's health while extending patient access to crisis support services.
  • Australian Council on Healthcare Standards (ACHS)flagshipOthersEucalyptus is the only telehealth company accredited by ACHS against the EQuIP6 standard, providing independent validation of clinical governance, patient safety and quality systems. ACHS accreditation is a strong differentiator versus other Australian telehealth operators.
  • Randox Laboratories LtdcoreImplementation/ SI/ Consulting PartnerUK diagnostic and pathology partner used by Eucalyptus to facilitate blood-testing services in the UK. Both parties act as separate and independent data controllers for the testing data.
  • Thriva LimitedcoreImplementation/ SI/ Consulting PartnerUK diagnostic and pathology partner used by Eucalyptus for at-home blood-testing kits and lab analysis. Both parties act as separate and independent data controllers for the testing data.
  • Australian Government's IHI Database (Healthcare Identifiers)coreTechnology or IntegrationEucalyptus has integrated with Australia's Individual Healthcare Identifier (IHI) database, allowing practitioners to validate patient identity and clinical history as part of safe prescribing workflows.
  • eRx Exchange (Australia)coreTechnology or IntegrationEucalyptus has integrated with Australia's eRx electronic prescription exchange to enable paperless prescribing and dispensing workflows across its clinics.

Scale indicators26 records

Recent moves13 records

Expansion highlights6 records

Eucalyptus competitors and assessment

Company assessment

Direct peers

  • Ro: US-based direct-to-consumer telehealth operator running Roman (men's health), Rory (women's health) and Ro Body (weight management). Closely comparable to Eucalyptus in multi-brand D2C prescribing model, subscription revenue structure and category mix across men's, women's and chronic care.
  • Maven Clinic: Virtual clinic for women's and family health covering fertility, maternity, postpartum and ongoing care. Directly comparable to Eucalyptus' Kin Fertility brand and adjacent to Juniper's women's weight-management focus.
  • Numan: UK-based D2C telehealth clinic treating men's health conditions (hair loss, erectile dysfunction, weight loss) via subscription. Direct peer to Eucalyptus' Pilot brand and representative of the same UK men's-health D2C category where Eucalyptus competes.
  • Zava: European online clinic operating across the UK, Germany, France and Ireland offering consultations, prescriptions and ongoing care for chronic and lifestyle conditions. Comparable to Eucalyptus in cross-European D2C prescription telehealth model and multi-country compliance footprint.
  • Noom: US-headquartered digital health platform combining behaviour change coaching with clinician-prescribed weight-loss pharmacotherapy (GLP-1 support). Closest pure-play peer to Eucalyptus' Juniper in combining coaching, app and prescription weight-management at scale.

Broad incumbents

  • Hims & Hers Health: NYSE-listed direct-to-consumer telehealth platform (HIMS) selling prescription and OTC treatments across hair, skin, sexual health, mental health and weight loss. Now Eucalyptus' parent company following the US$1.15B June 2026 acquisition, making it the closest functional peer and the channel through which Eucalyptus' brands now reach US consumers.
  • Teladoc Health: NYSE-listed global virtual care incumbent offering telehealth across primary care, mental health, chronic condition management and weight management (via Livongo acquisition). Broad incumbent peer providing enterprise and consumer virtual care at much larger scale than Eucalyptus.
  • Babylon Health: UK-founded digital health company offering AI-assisted triage, telehealth consultations and chronic-condition management globally. A broad incumbent peer in the UK/Europe telehealth market where Eucalyptus' Juniper and other brands operate.

Regional players

  • DoktorABC: Germany-focused online telehealth and pharmacy platform offering prescription treatments across weight management, men's health and dermatology. Regional peer in Germany where Eucalyptus operates Juniper Germany, with overlapping category mix.

Emerging players

  • Zoe: Personalised nutrition and metabolic health platform using at-home tests and consumer subscription coaching, with growing weight-management and cardiometabolic positioning. Emerging peer to Eucalyptus in consumer chronic-condition management with a science-led, evidence-base approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Eucalyptus social profiles

Digital presence

Eucalyptus compliance and trust

Trust signal

Compliance7 records

Eucalyptus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eucalyptus leadership team

Management profile

Number of profiles

Profiles16 records

Eucalyptus subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Eucalyptus funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eucalyptus M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eucalyptus

What does Eucalyptus do?

Eucalyptus operates a portfolio of subscription-based direct-to-consumer telehealth clinics (Juniper for women's weight management, Pilot for men's health, Kin for reproductive healthcare, Software for clinical-grade skincare, and Compound) delivered through its proprietary digital health platform. Patients access asynchronous and synchronous consultations with certified practitioners, receive clinician-prescribed medication, ongoing multidisciplinary coaching, and in some cases bespoke compounded or OTC treatments, paying recurring subscription fees for ongoing care and prescriptions.

Is Eucalyptus a public or private company?

Eucalyptus is a private company. It is classified as corporate owned and is currently acquired.

When was Eucalyptus founded?

Eucalyptus was founded in 2019. It employs 251 to 500 people.

Where is Eucalyptus based?

Eucalyptus is headquartered in Sydney, Australia, in the Oceania region.

How does Eucalyptus make money?

Four revenue lines are on record. Subscription Telehealth Programs are the primary driver. The others are skincare Product Sales (Software), contraceptive Pill Delivery (Kin) and telehealth Consultation & Treatment Fees.

Who are Eucalyptus's main competitors?

Direct peers on record are Ro, Maven Clinic, Numan, Zava and Noom. Broad incumbents are Hims & Hers Health, Teladoc Health and Babylon Health. DoktorABC is listed as a regional player. Zoe is listed as an emerging player.

Does Eucalyptus have an API?

No public API is recorded for Eucalyptus.

What industry is Eucalyptus in?

Eucalyptus's product category is Telehealth Healthcare Services. Its primary akta.pro industry code is HLALAFAK, Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care), with a secondary code of HLALALAK, Women’s & Family Health Provider Marketplaces. Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLeading Independent Proxy Advisor ISS Issues Condemnation of TNR Gold's Record; Eucalyptus Resources Thanks Shareholders For Outstanding Support to DateISS recommended shareholders vote on Eucalyptus Resources' GREEN proxy for TNR Gold, citing governance failures under Kirill Klip. Approximately 43% of shares have already voted for Eucalyptus Resources' nominees. The company urges remaining shareholders to vote for change.InsideretailHims & Hers launches online prescriptions in Australia after Eucalyptus dealHims & Hers began offering branded GLP-1 weight-loss drugs and other treatments to men in Australia after acquiring Eucalyptus, including its Pilot men's telehealth brand. The company plans to launch its women's health segment via Juniper later this year. Hims aims to reach US$6.5 billion in revenue by 2030.YahooHims & Hers’ Australia Expansion Adds Growth, But Execution Will Be KeyHims & Hers Health entered Australia by acquiring Eucalyptus, launching weight-loss and men's health treatments, with women's health services planned later this year. The move follows a 21% year-over-year increase in monthly revenue per subscriber, though international growth has pressured gross margins. The company aims to replicate its U.S. and European model toward its $6.5 billion 2030 revenue target.Insider Trading & Hedge Fund DataHims & Hers’ Australia Expansion Adds Growth, But Execution Will Be KeyHims & Hers Health entered Australia via its acquisition of Eucalyptus, rolling out weight-loss and men's health treatments with women's health services planned later this year. The move aims to replicate its U.S. and European model, though international growth has already pressured gross margins. Australia could become a growth engine toward its $6.5 billion 2030 revenue target.GurufocusHims Enters Australia, Marking First Expansion into the Asia-PacHims & Hers announced it is now serving customers in Australia, its first Asia-Pacific market, after acquiring Eucalyptus. The company expects the Australian market to help it reach $1B in international annual revenue within three years, with the Australian telehealth sector projected to grow to $2.56B by 2034.Business Wire BlogHims Enters Australia, Marking First Expansion into the Asia-Pacific MarketHims & Hers launched its brand in Australia, rebranding Eucalyptus' Pilot platform, marking its first Asia-Pacific presence. The company expects the Australian market to help it reach $1 billion in international annual revenue within three years, citing a $2.56 billion telehealth sector projection by 2034.Business Wire BlogHims Arrives in Australia, Bringing Personalised Care for Men NationwideHims & Hers launched its Hims brand in Australia, rebranding Eucalyptus' Pilot platform. The launch extends care team access to 24/7 and introduces combined treatments for premature ejaculation and cholesterol. It marks the company's first Asia-Pacific market entry.FinancialContent Business PageHims Enters Australia, Marking First Expansion into the Asia-Pacific MarketHims & Hers announced it is now serving customers in Australia, its first Asia-Pacific market, after acquiring Eucalyptus. The rebrand of Pilot to Hims aims to convert unmet demand in regional Australia, with the company targeting $1 billion in international annual revenue within three years.Stock TitanHims Enters Australia, Targets $1B International RevenueHims & Hers announced it is now serving customers in Australia, marking its first Asia-Pacific presence. The entry follows the rebranding of Pilot, Eucalyptus' men's health platform, and targets $1 billion in international annual revenue within three years. The Australian telehealth sector is projected to reach $2.56 billion by 2034.Seeking AlphaHims & Hers: Buying The Margin Dip (NYSE:HIMS)Hims & Hers Health reported a 17-fold year-over-year surge in international revenue to $131 million, driven by the Eucalyptus acquisition and expansion into new markets. The company is targeting over $600 million in international revenue for 2026 while investing in AI to reduce customer support costs and improve retention. Additionally, its testosterone therapy business is scaling rapidly, poised to become its sixth specialty category exceeding $100 million in U.S. revenue.